Leiden Bio Science Park Secures International Pharmaceutical Investments for Advanced Gene Therapy Manufacturing
The Leiden Bio Science Park secured massive foreign direct investment from a coalition of North American pharmaceutical companies to build specialized manufacturing facilities for advanced gene and cell therapies, cementing the Dutch life sciences ecosystem as a premier European hub for complex biopharmaceutical supply chains.